In the past week, TCBP stock has gone up by 34.22%, with a monthly gain of 5.26% and a quarterly surge of 125.98%. The volatility ratio for the week is 7.75%, and the volatility levels for the last 30 days are 10.14% for TC BioPharm (Holdings) plc ADR The simple moving average for the last 20 days is 30.67% for TCBP stock, with a simple moving average of -63.90% for the last 200 days.
Is It Worth Investing in TC BioPharm (Holdings) plc ADR (NASDAQ: TCBP) Right Now?
Moreover, the 36-month beta value for TCBP is 0.17. Analysts have varying opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
On May 06, 2024, TCBP’s average trading volume was 4.50M shares.
TCBP) stock’s latest price update
TC BioPharm (Holdings) plc ADR (NASDAQ: TCBP) has seen a rise in its stock price by 36.98 in relation to its previous close of 1.46. However, the company has experienced a 34.22% gain in its stock price over the last five trading sessions. InvestorPlace reported 2024-05-06 that TC BioPharm (NASDAQ: TCBP ) stock is rocketing higher on Monday after the clinical-stage biopharmaceutical company announced a major deal to acquire another company. According to a press release from TC BioPharm, it intends to acquire a private biotechnology company developing Chimeric Antigen Receptor T-cell (CAR-T) therapies.
TCBP Trading at 35.86% from the 50-Day Moving Average
After a stumble in the market that brought TCBP to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -91.23% of loss for the given period.
Volatility was left at 10.14%, however, over the last 30 days, the volatility rate increased by 7.75%, as shares surge +15.45% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +95.71% upper at present.
During the last 5 trading sessions, TCBP rose by +37.92%, which changed the moving average for the period of 200-days by -77.90% in comparison to the 20-day moving average, which settled at $1.5442. In addition, TC BioPharm (Holdings) plc ADR saw -36.91% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for TCBP
The total capital return value is set at -3.41. Equity return is now at value -94.90, with -13.34 for asset returns.
Based on TC BioPharm (Holdings) plc ADR (TCBP), the company’s capital structure generated 0.4 points at debt to capital in total, while cash flow to debt ratio is standing at -5.85. The debt to equity ratio resting at 0.67. The interest coverage ratio of the stock is 171.51.
Currently, EBITDA for the company is -17.35 million with net debt to EBITDA at 0.05. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.09.
Conclusion
To wrap up, the performance of TC BioPharm (Holdings) plc ADR (TCBP) has been mixed in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
